Shire (SHP)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4125.00p Today's change: +0.54%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4125.00p 5 day change: -2.22%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4125.00p 6 month change: +10.89%

Contact details

Address: 22 Grenville Street, St Helier, Jersey
Phone: +44 (0) 1256 894 000
Fax: +44 (0) 1256 894 708
Website: www.shire.com

Company information

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

Worldwide deal making passed $2 trillion (£1.49 trillion) yesterday, pushing on from the all-time high set at [...]

22 May 2018
Shares
1
Views
1,345

The haemophilia treatment drug Hemlibra is set to take up a dominant position on the market as it dramatically [...]

21 May 2018
Views
138

What links Paul Walsh, Sir Nigel Rudd and Vagn Sorensen? Other than chairing three of the London market’s blue-chip [...]

18 May 2018
Shares
1
Views
461

The FTSE has continued to rally this morning, buoyed by a strong performance on Wall Street overnight and positive [...]

8 May 2018
Views
154

Shire shareholders are witnessing billions of pounds being wiped off the value of a takeover by Japanese pharmaceutical [...]

25 April 2018
Shares
4
Views
427

Investors are quite rightly concerned over debt-fuelled acquisitions, as history is littered with companies that [...]

25 April 2018
Views
232

Japanese pharmaceuticals giant Takeda today made a fresh approach for London-listed rival Shire, with a deadline [...]

24 April 2018
Shares
2
Views
714

The FTSE 100 has continued the slow climb it began at the beginning of this week, closing today at 7,361.56 [...]

20 April 2018
Views
181

A bidding war is on the cards for Ireland-based pharmaceuticals giant Shire as Botox maker Allergan wades into [...]

19 April 2018
Views
154

Shares in London-listed pharmaceuticals giant Shire got a shot in the arm this morning after it emerged Japan's [...]

19 April 2018
Views
682

London-listed rare disease specialist Shire is facing criticism over executive pay from leading shareholder advisory [...]

18 April 2018
Views
311

Shares in Ireland-based biotech Shire have zoomed up two per cent this morning after it revealed it will sell [...]

16 April 2018
Shares
5
Views
252

Healthcare is big business, and pharmaceuticals have done well by investors. But is there any life left in this [...]

10 April 2018
Shares
3
Views
687

Shares in Japanese pharmaceuticals giant Takeda dropped today after the company was forced to reveal it was mulling [...]

29 March 2018
Views
357

Facebook founder Mark Zuckerbeg had another difficult week after he was criticised for refusing to appear before [...]

29 March 2018
Views
386

Content tagged with "Shire"